|
Volumn 92, Issue 4, 2013, Pages 557-558
|
Profound neurological injury in a patient with atypical hemolytic uremic syndrome
|
Author keywords
[No Author keywords available]
|
Indexed keywords
COMPLEMENT COMPONENT C3;
ECULIZUMAB;
VON WILLEBRAND FACTOR CLEAVING PROTEINASE;
MONOCLONAL ANTIBODY;
ACUTE KIDNEY FAILURE;
AGED;
BRAIN DISEASE;
CASE REPORT;
CLINICAL FEATURE;
COMPLEMENT C3 GENE;
COMPUTER ASSISTED TOMOGRAPHY;
DETERIORATION;
DIAGNOSTIC IMAGING;
DISEASE ASSOCIATION;
DRUG EFFECT;
DRUG RESPONSE;
ELECTROENCEPHALOGRAM;
ENZYME ACTIVITY;
ENZYME ASSAY;
FEMALE;
GENE;
GENE MUTATION;
HEMOLYTIC UREMIC SYNDROME;
HUMAN;
IMAGE ANALYSIS;
LETTER;
LUMBAR PUNCTURE;
MAINTENANCE THERAPY;
MEDICAL HISTORY;
NEUROLOGIC DISEASE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PATIENT TRANSPORT;
PLASMAPHERESIS;
PRIORITY JOURNAL;
THROMBOCYTE COUNT;
THROMBOTIC THROMBOCYTOPENIC PURPURA;
TONIC CLONIC SEIZURE;
PATHOLOGY;
SEIZURE;
SEVERITY OF ILLNESS INDEX;
AGED;
ANTIBODIES, MONOCLONAL, HUMANIZED;
BRAIN DISEASES;
FEMALE;
HEMOLYTIC-UREMIC SYNDROME;
HUMANS;
SEIZURES;
SEVERITY OF ILLNESS INDEX;
|
EID: 84877018743
PISSN: 09395555
EISSN: 14320584
Source Type: Journal
DOI: 10.1007/s00277-012-1615-y Document Type: Letter |
Times cited : (18)
|
References (4)
|